Literature DB >> 4036568

Hyperpressure in juvenile hip disease.

P Kallio, S Ryöppy.   

Abstract

Intra-articular pressure was measured in 94 hips in 81 children with Perthes' disease and various forms of synovitis of the hip. The pressure was elevated in Perthes' disease (3.4 kPa), transient synovitis (17.3 kPa), septic arthritis (20.2 kPa), reactive arthritis (28.0 kPa) and arthritis with urticaria (32.3 kPa). In transient synovitis the mean pressure was only 2.3 kPa in flexion, while a mean of 26.6 kPa was seen in the neutral position and in internal rotation. In children with synovial effusion of the hip, the position of immobilisation should therefore be in flexion of 30-45 degrees with slight external rotation. The neutral position or extension, even with simultaneous traction, may endanger the circulation of the femoral head.

Entities:  

Mesh:

Year:  1985        PMID: 4036568     DOI: 10.3109/17453678508992996

Source DB:  PubMed          Journal:  Acta Orthop Scand        ISSN: 0001-6470


  6 in total

1.  The painful hip.

Authors:  P K Dave
Journal:  Indian J Pediatr       Date:  1990 May-Jun       Impact factor: 1.967

2.  Alternative to crutches?

Authors:  Bernhard Heimkes
Journal:  Dtsch Arztebl Int       Date:  2010-01-29       Impact factor: 5.594

3.  [Current treatment strategies in Legg-Calvé-Perthes disease].

Authors:  B Westhoff; F Martiny; R Krauspe
Journal:  Orthopade       Date:  2013-12       Impact factor: 1.087

4.  Legg-Calvé-Perthes disease: role of isolated adductor tenotomy?

Authors:  Joaquín Moya-Angeler; Juan Carlos Abril; Ignacio Varo Rodriguez
Journal:  Eur J Orthop Surg Traumatol       Date:  2012-10-30

5.  Hip range of motion in Perthes' disease: comparison of pre-operative and intra-operative values.

Authors:  Carl L Stanitski
Journal:  J Child Orthop       Date:  2007-03-03       Impact factor: 1.548

6.  Ultrasonography of the hip for Perthes' disease.

Authors:  F J Linnenbaum; H Woltering; A Karbowski; A Härle
Journal:  Arch Orthop Trauma Surg       Date:  1989       Impact factor: 3.067

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.